The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinomaManfred Johannsen, Filippo de Braud, Leonardo Giovannoni et al.|European Journal of Cancer|2010Cited by 187
Metabolic profiling reveals key metabolic features of renal cell carcinomaGareth Catchpole, Steffen Weikert, Alexander Platzer et al.|Journal of Cellular and Molecular Medicine|2009Cited by 118
Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone TreatmentJens Köllermann, Klaus Pantel, Steffen Weikert et al.|Journal of Clinical Oncology|2008Cited by 83
Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomyZofia Wotschofsky, Klaus Jung, Jonas Busch et al.|Clinica Chimica Acta|2012Cited by 66
Promoter Hypermethylation Profile of Kidney Cancer with New Proapoptotic p53 Target Genes and Clinical ImplicationsFrank Christoph, Mark Schrader, Steffen Weikert et al.|Clinical Cancer Research|2006Cited by 56